Advertisement
UK markets closed

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     

  • AIM

    789.87
    +6.17 (+0.79%)
     

  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     

  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     

  • Bitcoin GBP

    48,462.85
    -1,727.44 (-3.44%)
     

  • CMC Crypto 200

    1,257.62
    -100.39 (-7.39%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     
MONEY:

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

BRIEF-Shanghai RAAS Blood Products Plans To Acquire Tiancheng (Germany), Spain's Grifols Diagnostic Solutions

Reuters

Nov 22 (Reuters) - Shanghai RAAS Blood Products Co Ltd :

* SAYS IT PLANS TO BUY TIANCHENG (GERMANY), WHICH OWNS ABOUT 90 PERCENT OF BIOTEST AG, FOR 589 MILLION EUROS (NOT TO BUY GERMANY'S BIOTEST FOR 589 MILLION EUROS), SPAIN'S GRIFOLS DIAGNOSTIC SOLUTIONS FOR $5.0 BILLION

* SAYS GRIFOLS DIAGNOSTIC SOLUTIONS' PARENT GRIFOLS, S.A WILL BECOME CO'S STRATEGIC SHAREHOLDER

* SAYS PLANNED ACQUISITIONS ARE PENDING REGULATORY APPROVALS

* SAYS IT HALTED PLAN TO BUY BIO PRODUCTS LABORATORY HOLDINGS DUE TO SINO-U.S. TRADE TENSIONS, RISING UNCERTAINTIES TO OBTAIN CFIUS APPROVAL Source text in Chinese: https://bit.ly/2QeJgr1 Further company coverage: (Reporting by Hong Kong newsroom)